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c-AMP dependent protein kinase A inhibitory activity of six algal extracts from
South Eastern Australia and their fatty acid composition
Abstract
c-AMP dependent protein kinase (protein kinase A, PKA) is an important enzyme involved in the
regulation of an increasing number of physiological processes including immune function, cardiovascular
disease, memory disorders and cancer. The objective of this study was to evaluate the PKA inhibitory
activity of a range of algal extracts, along with their fatty acid composition. Six algal species were
investigated including two Chlorophyta (Codium dimorphum and Ulva lactuca), two Phaeophyta
(Phyllospora comosa and Sargassum sp.) and two Rhodophyta (Prionitis linearis and Corallina
vancouveriensis), with the order of PKA inhibitory activity of their extracts identified as follows: brown
seaweeds > red seaweeds > green seaweeds with the brown alga Sargassum sp. exhibiting the highest
PKA inhibitory activity (84% at 100 microg/mL). GC/MS analysis identified a total of 18 fatty acids in the
six algal extracts accounting for 72-87% of each extract, with hexadecanoic acid and
9,12-octadecadienoic acid as the dominant components. The most active extract (Sargassum sp.) also
contained the highest percentage of the saturated C14:0 fatty acid (12.8% of the total extract), which is a
known to inhibit PKA. These results provide the first description of the PKA inhibitory activity of marine
algae along with the first description of the fatty acid composition of these six algal species from South
Eastern Australian waters. Importantly, this study reveals that abundant and readily available marine algae
are a new and relatively unexplored source of PKA inhibitory compounds.
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c-AMP Dependent protein kinase (protein kinase A, PKA) is an important enzyme involved in the regulation of an increasing number of physiological
processes including immune function, cardiovascular disease, memory disorders and cancer. The objective of this study was to evaluate the PKA inhibitory
activity of a range of algal extracts, along with their fatty acid composition. Six algal species were investigated including two Chlorophyta (Codium
dimorphum and Ulva lactuca), two Phaeophyta (Phyllospora comosa and Sargassum sp.) and two Rhodophyta (Prionitis linearis and Corallina
vancouveriensis), with the order of PKA inhibitory activity of their extracts identified as follows: brown seaweeds > red seaweeds > green seaweeds with the
brown alga Sargassum sp. exhibiting the highest PKA inhibitory activity (84% at 100 μg/mL). GC/MS analysis identified a total of 18 fatty acids in the six
algal extracts accounting for 72-87% of each extract, with hexadecanoic acid and 9,12-octadecadienoic acid as the dominant components. The most active
extract (Sargassum sp.) also contained the highest percentage of the saturated C14:0 fatty acid (12.8% of the total extract), which is a known to inhibit PKA.
These results provide the first description of the PKA inhibitory activity of marine algae along with the first description of the fatty acid composition of these
six algal species from South Eastern Australian waters. Importantly, this study reveals that abundant and readily available marine algae are a new and relatively
unexplored source of PKA inhibitory compounds.
Keywords: protein kinase A, enzyme inhibitors, algae, fatty acids.

Kinases play a key role in cell regulation and their deregulation is a
hallmark of a number of diseases including cancer [1]. PKA has
received increasing attention in recent years as it is found to play a
vital role in a myriad of physiological processes [2], in particular
immune function [3] and memory disorders such as Alzheimer’s
and Parkinson’s disease [4], where it has become an attractive new
drug target. Interestingly, there are as yet no PKA inhibitors
reported from any marine sources.
Marine algae are well known as rich sources of bioactive natural
products of diverse chemical structures and with a great range of
biological activities [5]. The nutritional value of marine algae is
also of importance as they have a high content of vitamins and
minerals and are an important source of essential fatty acids (FAs)
[6,7]. Marine algae contain a complex mixture of fatty acids of
greater variety than those found in vascular plants [8] and are
particularly rich in polyunsaturated fatty acids (PUFAs) [9]. Fatty
acids are important for a wide array of cell structure components
and for many biological, physiological and chemical processes in
the body [7]. Biochemical analysis, in particular fatty acid
composition, has been used for the taxonomic classification of

various algal species [6,9]. Marine algae are also rich in
halogenated compounds, polyphenols and polysaccharides, which
display a wide range of activities including anticoagulant, antiviral,
antioxidative, anticancer and immunomodulating activities [10]. A
number of promising anticancer compounds are derived from algae
including stypoldione from the brown alga Stypopodium zonale,
which inhibits polymerization of microtubules, and the cytotoxic
dehydrothysiferol isolated from the red alga Laurencia viridis,
active against a number of human breast cancer cell lines [11].
Given the impressive bioactivity profiles of algal metabolites, the
aim of the present work was to screen a range of algal extracts for
their ability to inhibit PKA, along with obtaining their fatty acid
profiles. The green seaweeds Codium dimorphum and Ulva lactuca,
the brown seaweeds Phyllospora comosa and Sargassum sp. and the
red seaweeds Prionitis linearis and Corallina vancouveriensis, were
collected from two locations along the New South Wales coast of
Australia known to be ‘biodiversity hotspots’ [12]. The six algal
species investigated were chosen due to their high abundance in the
collection area, their accessibility and as these species had not been
studied previously from South Eastern Australian waters.

Table 1. Algal species collected, class, collection place and % PKA inhibitory activity.
No Algal species
Class
Collection Place
1
Codium dimorphum
Chlorophyta
Belambi Point, NSW
2
Ulva lactuca
Chlorophyta
Austinmer, NSW
3
Phyllospora comosa
Phaeophyta
Belambi Point, NSW
4
Sargassum sp.
Phaeophyta
Austinmer, NSW
5
Prionitis linearis
Rhodophyta
Austinmer, NSW
6
Corallina vancouveriensis
Rhodophyta
Austinmer, NSW

Latitude
34º 21' S
34º 18' S
34º 21' S
34º 18' S
34º 18' S
34º 18' S

Longitude
150º 56' E
150º 56' E
150º 56' E
150º 56' E
150º 56' E
150º 56' E

% PKA inhibition
28 ± 0.4
18 ± 3.0
55 ± 1.6
84 ± 5.3
37 ± 3.4
30 ± 1.1

†
All samples were collected from the South Eastern region of New South Wales (NSW), Australia. All measurements were performed in triplicate at a final concentration
of 100 μg/mL. Biological data are presented as the mean values ± S.E.M from triplicate measurements.

The highest PKA inhibitory activities were displayed by the
dichloromethane extracts of the two brown algae Sargassum sp. and

P. comosa (with 84% and 55% inhibition, respectively). The two
red algal species, P. linearis and C. vancouveriensis, displayed

similar activities of 38% and 30% respectively, while the two green
algal dichloromethane extracts showed <30% activity. A small
number of algal-derived kinase inhibitors have been described
previously including the tyrosine kinase inhibitor stypoquinonic
acid from the brown algae Stypopodium zonale; sulfated
triterpenoids from the green algae Tuemoya sp. as tyrosine kinase
Tie2 inhibitors; and cycloartanol derivatives from the green algae
Tydemania expeditionis as inhibitors of pp60v-src [13]. However, this
is the first report of marine algal extracts exhibiting PKA inhibitory
activity and suggests that they may be an important new source of
PKA inhibitors in the future.
A total of 18 different fatty acids were identified in the samples
comprising six saturated and eleven unsaturated straight chain fatty
acids and one branched fatty acid. The GC-MS analysis of the six
algal extracts identified hexadecanoic acid and 9,12octadecadienoic acid as the dominant fatty acids. Hexadecanoic
acid was the main acid in five of the six samples (ranging from
23.3-32.1% of the total extract), whilst only in C. dimorphum the
major acid was 9,12-octadecadienoic acid (22.4%), followed by
hexadecanoic acid (20.6%). The percentages of these two fatty
acids were significantly higher than the amount of the other
compounds in all extracts. These results are consistent with
previous reports where hexadecanoic acid was identified in high
percentages in various algal species including U. lactuca from
China [6], U. fenestrata from Japan [14]; Sargassum sp. from Japan
[7,15]; P. linearis from California [16]; Corallina granifera from
the Black Sea [17], C. dimorphum from Chile [8], and Phyllospora
comosa from Tasmania, Australia [18].
Some similarity was observed in the fatty acid composition of the
six algal species. For example, U. lactuca, P. comosa and C.
vancouveriensis had similar fatty acid compositions with only small
differences in the type and relative percentages of some acids. The
highest number of identified fatty acids (18 fatty acids), was found

in the red algae C. vancouveriensis, followed by 17 fatty acids in
the brown algae P. comosa, with the lowest number (10 fatty acids),
found in the green algae C. dimorphum. PUFAs of C18, C20 and C22
chain length were detected among the six species but only in low
overall percentages. C. vancouveriensis and P. comosa contained
the highest proportion of PUFAs (10.7% and 10.1% respectively),
while a lower number were found in the Sargassum sp, U. lactuca
and P. linearis and no PUFAs were detected at all in C. dimorphum.
The ratio of saturated: unsaturated acids varied from 1:2 in Codium
dimorphum and Phyllospora comosa to 1:1 in all others. The fatty
acid compositions of some of the species investigated herein have
been described previously [7,8,15,18,19], however this is the first
report of the fatty acid composition of these species collected from
South Eastern Australian waters, and the first description of the
PKA inhibitory activity of any marine algal extracts.
As fatty acids accounted for the major part of the extracts examined
(i.e. 72-87% of the total extract), it is likely that they are responsible
for, or at least contribute in part to, the observed PKA inhibitory
activity of the extracts. ω-Fatty acids have been reported to inhibit
related protein kinases such as PKC [21]. Furthermore, previous
studies in our group [20] have shown that the saturated fatty acid
C14:0 shows strong PKA inhibitory activity, and C16:0, C18:0 and
C18:1 fatty acids moderate activity at the same concentration as that
used herein (100 µg/mL). Interestingly, the most active algal
extract, that of the Sargassum sp., also contained the highest
percentage (12.8%) of the more potent PKA inhibitory C14:0 fatty
acid. The Prionitis linearis extract, which showed only moderate
PKA inhibitory activity, had the highest proportion (32.1%) of the
C16:0 fatty acid, which is known to inhibit PKA at a similar
moderate level of activity [20]. It should, however, also be noted
that the remainder of the non-polar extract examined comprised
aldehydes, hydrocarbons and alcohols, which could also contribute
to the observed biological activity.

Table 2: Fatty acid composition of the dichloromethane extracts from the SE Australian marine algae
Chlorophyta
Phaeophyta
Rhodophyta
No.
Fatty acids
Type
1
2
3
4
5
6
1
Tetradecanoic acid
14:0
2.1
6.0
5.4
12.8
4.0
5.8
2
12-Methyltetradecanoic acid
15:0
0.7
0.3
0.1
3
Hexadecanoic acid
16:0
20.6
25.5
23.3
23.3
32.1
24.9
4
7-Hexadecenoic acid
16:1 n-9
0.1
0.2
5
9-Hexadecenoic acid
16:1 n-7
15.4
3.5
4.4
3.6
6.3
2.3
6
Heptadecanoic acid
17:0
1.2
1.7
0.3
0.5
7
Octadecanoic acid
18:0
2.3
0.4
0.5
1.9
2.3
1.2
8
9-Octadecenoic acid
18:1 n-9
7.2
3.1
4.5
4.4
2.2
8.8
9
9,12-Octadecadienoic acid
18:2 n-6
22.4
14.9
20.0
16.5
26.7
19.3
10
6,9,12-Octadecatrienoic acid
18:3 n-6
1.9
0.7
0.4
1.2
1.8
0.9
11
6,9,12,15-Octadecatetranoic acid
18:4 n-3
0.3
0.4
0.1
12
Eicosanoic acid
20:0
tr
0.1
0.4
13
11,14-Eicosadienoic acid
20:2 n-6
5.8
8.8
14.3
8.3
7.0
6.2
14
8,11,14-Eicosatrienoic acid
20:3 n-6
4.8
4.7
5.4
11.3
4.2
5.2
15
5,8,11,14-Eicosatetraenoic acid
20:4 n-6
0.9
1.4
0.5
0.9
0.5
16
5,8,11,14,17-Eicosapentaenoic acid
20:5 n-3
1.3
0.7
1.7
1.1
1.6
17
7,10,13,16,19-Docosapentaenoic acid
22:5 n-3
0.1
0.1
18
Tricosanoic acid
23:0
0.2
0.2
0.3
83.2
71.6
82.9
86.0
88.6
78.4
% of Total extract
Six algae species analysed: 1: Codium dimorphum; 2: Ulva lactuca; 3: Phyllospora comosa; 4: Sargassum sp.; 5: Prionitis linearis ; 6: Corallina
vancouveriensis; tr – trace amounts (< 0.1).

In summary, as part of a wider screening program aimed at
identifying novel therapeutic agents from Australian marine fauna,

a range of algae from SE Australia were screened for PKA
inhibitory activity, with the most potent activity (84% at 100
µg/mL) exhibited by the brown alga Sargassum sp. The biological
activity of the algal extracts was reflected in the different algal
divisions, with the order of PKA inhibitory activity identified as:
brown seaweeds > red seaweeds > green seaweeds. The fatty acid
composition of all six algal species investigated was dominated by
hexadecanoic and 9,12-octadecadienoic acid and comprised a 2:1 to
1:1 ratio of unsaturated:saturated fatty acids. Some of these fatty
acids are likely to contribute to the observed PKA inhibitory
activities of the algal extracts and their further investigation is
currently underway.
Experimental
Collection: A summary of the species collected, taxonomic class,
and collection place is provided in Table 1. The algae were
collected from the intertidal zone by hand during the period
March/April 2008 under Scientific Research Permit Number
F95/269-4.0 issued by the New South Wales (NSW) Department of
Fisheries, Australia and stored frozen (-20 °C) until extraction.
Voucher specimens are held at the University of Wollongong,
NSW, Australia (AZ061, AZ073, AZ056, AZ072, AZ076, and
AZ077).
Extract Preparation: The frozen algal tissue was macerated and
exhaustively extracted with CH2Cl2 (20-50 ml / g tissue) and then
MeOH. The solvents were combined and removed in vacuo at 30
°C. The crude extract was then extracted with CH2Cl2 to yield 0.34.6 g of CH2Cl2-soluble material upon evaporation that was
subjected to GC and GC/MS analyses. Stock solutions of 1mg/mL
of the CH2Cl2-extract were prepared in 20% DMSO and further
diluted by 1:10 in the assay to give a final concentration of
100 µg/mL (in 2% DMSO).
GC: GC Analyses were performed on a Shimadzu GC-2100 Plus
system equipped with a BP-5 fused silica Rxi-5ms capillary column
(5% phenyl/95% dimethyl polysiloxane, 30 m x 0.25 mm, 0.25 μm

film thickness, Restek), using hydrogen carrier gas (1.0 mL/mn) and
samples of 1 μL . The oven was programmed at 40 °C at 4 °C per
minute to 290 °C and held at 290 °C for 5 minutes.
GC/MS: GC/MS Analyses were performed on a Shimadzu QP5050A GC-MS system with a mass selective detector operated in
the EI mode (70 eV0) and equipped with a BP-5 fused silica Rxi5ms capillary column (5% phenyl/95% dimethyl polysiloxane, 30 m
x 0.25 mm, 0.25 μm film thickness, Restek), using helium carrier
gas (1.0 mL/mn) and samples of 1 μL over the temperature range
80-300 °C. The relative intensity of each peak was calculated as a
percentage of the summed total. Fatty acids were detected as their
methyl esters after treatment with methanolic boron trifluoride and
their identification was based on comparisons of the mass spectral
fragmentation patterns to the NIST 08 mass spectral database and
comparison with authentic standards where possible. Replicate
GC/MS analyses performed on samples gave identical results.
Biological Activity: PKA inhibitory activity was determined using
the Kinase-Glo® Luminescent Kinase Assay (Promega Corporation,
Madison, USA). Each well of an opaque white 96 well plate
(Corning) contained 5 µl of sample, 25 µl of ATP (20 µM), and 20
µl of a mixture of kinase (0.1unit/µL) and Kemptide substrate (140
µM) in reaction buffer (40 mM Tris, 20mM MgCl2, BSA
0.1mg/mL, pH 7.4). After 1 hr incubation at RT, 50 µL of the
Kinase-Glo® Reagent was added, the mixture incubated for 15 mn
and luminescence measured on a BMG Labtech FLUOstar Optima®
luminometer. Data were determined relative to positive controls that
contained solvent in place of sample. Negative controls contained
no substrate. Staurosporine (IC50 = 7 nM) was used as an internal
standard. All measurements were performed in triplicate and in at
least two independent experiments for reproducibility. Data are
presented as the mean values ± S.E.M.
Acknowledgments - This work was supported financially by the
University of Wollongong (UOW) through the Centre for Medicinal
Chemistry and a UOW University Postgraduate Award (AZ).

References
[1]
[2]
[3]
[4]
[5]

[6]
[7]
[8]
[9]
[10]

Hanahan D, Weinberg RA. (2000) The hallmarks of cancer. Cell, 100, 57-70.
Tasken K, Aandahl EM. (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiological Reviews,
84, 137-167.
Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Tasken K. (2002) Molecular mechanisms for protein kinase A-mediated
modulation of immune function. Cellular Signalling, 14, 1-9.
Arnsten AFT, Ramos BP, Birnbaum SG, Taylor JR. (2005) Protein kinase A as a therapeutic target for memory disorders: rationale
and challenges. Trends in Molecular Medicine, 11, 121-128.
a) Kanias GD, Skaltsa H, Tsitsa E, Loukis A, Bitis J. (1992) Study of the correlation between trace-elements, sterols and fatty acids
in brown-algae from the Saronikos Gulf of Greece. Fresenius Journal of Analytical Chemistry, 344, 334-339; b) Demirel Z,
Yilmaz-Koz FF, Karabay-Yavasoglu UN, Ozdemir G, Sukatar A. (2009) Antimicrobial and antioxidant activity of brown algae from
the Aegean Sea. Journal of the Serbian Chemical Society, 74, 619–628.
Li XC, Fan X, Han LJ, Lou QX. (2002) Fatty acids of some algae from the Bohai Sea. Phytochemistry, 59, 157-161.
Orhan I, Sener B, Atici T. (2003) Fatty acid distribution in the lipoid extracts of various algae. Chemistry of Natural Compounds,
39, 167-170.
Goecke F, Hernandez V, Bittner M, Gonzalez M, Becerra J, Silva M. (2010) Fatty acid composition of three species of Codium
(Bryopsidales, Chlorophyta) in Chile. Revista De Biologia Marina Y Oceanografia, 45, 325-330.
Heiba HI, Al-Easa HS, Rizk AFM. (1997) Fatty acid composition of twelve algae from the coastal zones of Qatar. Plant Foods for
Human Nutrition, 51, 27-34.
a) Wijesekara I, Pangestuti R, Kim SK. (2011) Biological activities and potential health benefits of sulfated polysaccharides derived
from marine algae. Carbohydrate Polymers, 84, 14-21; b) Jiao GL, Yu GL, Zhang JZ, Ewart HS. (2011) Chemical Structures and

Zivanovic A et al.

[11]

[12]
[13]

[14]
[15]
[16]
[17]
[18]
[19]

[20]

[21]

Bioactivities of Sulfated Polysaccharides from Marine Algae. Marine Drugs, 9, 196-223; c) La Barre S, Potin P, Leblanc C, Delage
L. (2010) The Halogenated Metabolism of Brown Algae (Phaeophyta), Its Biological Importance and Its Environmental
Significance. Marine Drugs, 8, 988-1010; and d) Beress A, Wassermann O, Bruhn T, et al. (1993) A new procedure for the isolation
of Anti-HIV compounds (Polysaccharides and Polyphenols) from the marine algae Fucus vesiculosus. Journal of Natural Products,
56, 478-488; Li YQ, Zhang XW, Chen G, Wei D, Chen F. (2008) Algal lectins for potential prevention of HIV transmission. Current
Medicinal Chemistry, 15, 1096-1104.
a) Obrien ET, White S, Jacobs RS, Boder GB, Wilson L. (1984) Pharmacological properties of a marine natural product,
Stypolidone, obtained from the brown alga Stypodium zonale. Hydrobiologia, 116, 141-145; b) Pec MK, Moser-Thier K, Fernandez
JJ, Souto ML, Kubista E. (1999) Growth inhibition by dehydrothyrsiferol - a non-Pgp modulator, derived from a marine red alga in human breast cancer cell lines. International Journal of Oncology, 14, 739-743.
Phillips JA. (2001) Marine macroalgal biodiversity hotspots: why is there high species richness and endemism in southern
Australian marine benthic flora? Biodiversity and Conservation, 10, 1555-1577.
a) Wessels M, Konig GM, Wright AD. (1999) A new tyrosine kinase inhibitor from the marine brown alga Stypopodium zonale.
Journal of Natural Products, 62, 927-930; b) Clement JA, Zhou BN, Johnson RK, Kingston DGI. (2003) Isolation and
characterization of a Tie2 kinase inhibitory sulfated triterpenoid from a green alga of the Tuemoya genus: complete assignment of
the H-1 and C-13 spectra of a sulfated triterpenoid Tie2 kinase inhibitor. Magnetic Resonance in Chemistry, 41, 644-646; c)
Govindan M, Abbas SA, Schmitz FJ, Lee RH, Papkoff JS, Slate DL. (1994) New cycloartanol sulfates from the alga Tydemania
expeditionis. Inhibitors of the protein tyrosine kinase pp60v-src. Journal of Natural Products, 57, 74-78.
Khotimchenko SV. (1993) Fatty-acids of green macrophytic algae from the sea of Japan. Phytochemistry, 32, 1203-1207.
Sanina NM, Goncharova SN, Kostetsky EY. (2004) Fatty acid composition of individual polar lipid classes from marine
macrophytes. Phytochemistry, 65, 721-730.
Khotimchenko SV, Vaskovsky VE, Titlyanova TV. (2002) Fatty acids of marine algae from the pacific coast of north California.
Botanica Marina, 45, 17-22.
De Rosa S, Kamenarska Z, Stefanov K, et al. (2003) Chemical composition of Corallina mediterranea Areschoug and Corallina
granifera Ell. et Soland. Zeitschrift Fur Naturforschung C-a Journal of Biosciences, 58, 325-332.
Guest MA, Hirst AJ, Nichols PD, Frusher SD. (2010) Multi-scale spatial variation in stable isotope and fatty acid profiles amongst
temperate reef species: implications for design and interpretation of trophic studies. Marine Ecology Progress Series, 410, 25-41.
a) Bazes A, Silkina A, Douzenel P, et al. (2009) Investigation of the antifouling constituents from the brown alga Sargassum
muticum (Yendo) Fensholt. Journal of Applied Phycology, 21, 395-403; b) El-Naggar MEE. (1998) A comparative study of the
fatty acids in some marine algae from Saudi Arabia. Microbios, 96, 177-187; c) Frikha F, Kammoun M, Hammami N, et al. (2011)
Chemical composition and some biological activities of marine algae collected in Tunisia. Ciencias Marinas, 37, 113-124.
Zivanovic A, Pastro NJ, Fromont J, Thomson M, Skropeta D. (2011) Kinase inhibitory, haemolytic and cytotoxic activity of three
deep-water sponges from North Western Australia and their fatty acid composition. Natural Product Communications, 6, 19211924.
Massaro M, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R. (2006) The omega-3 fatty acid docosahexaenoate
attenuates vascular inflammation reducing endothelial cyclooxygenase-2 induction through the inhibition of both NADP(H)
oxidase and PKC epsilon. Circulation, 114, 120-120.

